|
1
|
Xie D, Li W, Wang Y, Gu H, Teo K, Liu L
and Yusuf S: INTERHEART China study Investigators: Sleep duration,
snoring habits and risk of acute myocardial infarction in China
population: Results of the INTERHEART study. BMC Public Health.
14:5312014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang J, Zhang G, Tian J, Li C, Jiang W,
Xing Y, Zhu H, Hou J, Xu H and Wu J: Cardioprotective effect of
SMND-309, a novel derivate of salvianolic acid B on acute
myocardial infarction in rats. Basic Clin Pharmacol Toxicol.
106:317–323. 2010.PubMed/NCBI
|
|
3
|
Wang X, Wang Y, Jiang M, Zhu Y, Hu L, Fan
G, Wang Y, Li X and Gao X: Differential cardioprotective effects of
salvianolic acid and tanshinone on acute myocardial infarction are
mediated by unique signaling pathways. J Ethnopharmacol.
135:662–671. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holmes D, Campbell M, Harbinson M and Bell
D: Protective effects of intermedin on cardiovascular, pulmonary
and renal diseases: Comparison with adrenomedullin and CGRP. Curr
Protein Pept Sci. 14:294–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang CY, Chen SY, Fu RH, Huang YC, Chen
SY, Shyu WC, Lin SZ and Liu SP: Differentiation of embryonic stem
cells into cardiomyocytes used to investigate the cardioprotective
effect of salvianolic acid B through BNIP3 involved pathway. Cell
Transplant. 24:561–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Antman EM, Anbe DT, Armstrong PW, Bates
ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas
GA, et al: American College of Cardiology; American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (Writing Committee to Revise the 1999 Guidelines for the
Management of Patients With Acute Myocardial Infarction): ACC/AHA
guidelines for the management of patients with ST-elevation
myocardial infarction - executive summary: a report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines (Writing Committee to Revise the 1999
Guidelines for the Management of Patients With Acute Myocardial
Infarction). Circulation. 110:588–636. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillum RF, Fortmann SP, Prineas RJ and
Kottke TE: International diagnostic criteria for acute myocardial
infarction and acute stroke. Am Heart J. 108:150–158. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gheeraert PJ, De Buyzere ML, Taeymans YM,
Gillebert TC, Henriques JP, De Backer G and De Bacquer D: Risk
factors for primary ventricular fibrillation during acute
myocardial infarction: A systematic review and meta-analysis. Eur
Heart J. 27:2499–2510. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dangas GD, Caixeta A, Mehran R, Parise H,
Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G,
Peruga JZ, et al: Harmonizing Outcomes with Revascularization and
Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Investigators: Frequency and predictors of stent thrombosis after
percutaneous coronary intervention in acute myocardial infarction.
Circulation. 123:1745–1756. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lindsey JB, Marso SP, Pencina M, Stolker
JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip
DE, et al: EVENT Registry Investigators: Prognostic impact of
periprocedural bleeding and myocardial infarction after
percutaneous coronary intervention in unselected patients: Results
from the EVENT (evaluation of drug-eluting stents and ischemic
events) registry. JACC Cardiovasc Interv. 2:1074–1082. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang HS and Wang SQ: Salvianolic acid B
from Salvia miltiorrhiza inhibits tumor necrosis factor-alpha
(TNF-alpha)-induced MMP-2 upregulation in human aortic smooth
muscle cells via suppression of NAD(P)H oxidase-derived reactive
oxygen species. J Mol Cell Cardiol. 41:138–148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou L, Zuo Z and Chow MS: Danshen: An
overview of its chemistry, pharmacology, pharmacokinetics, and
clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan H, Yang L, Fu F, Xu H, Meng Q, Zhu H,
Teng L, Yang M, Zhang L, Zhang Z and Liu K: Cardioprotective
effects of salvianolic acid a on myocardial ischemia-reperfusion
injury in vivoin vitro. Evid Based Complement Alternat Med.
2012:5089382012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Q, Wang S, Xie Y, Wang J, Li H, Zhou
X and Liu W: Effect of salvianolic acid B and paeonol on blood
lipid metabolism and hemorrheology in myocardial ischemia rabbits
induced by pituitruin. Int J Mol Sci. 11:3696–3704. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kandilci H Burak, Gumusel B, Wasserman A,
Witriol N and Lippton H: Intermedin/adrenomedullin-2 dilates the
rat pulmonary vascular bed: Dependence on CGRP receptors and nitric
oxide release. Peptides. 27:1390–1396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang JH, Qi YF, Jia YX, Pan CS, Zhao J,
Yang J, Chang JK and Tang CS: Protective effects of
intermedin/adrenomedullin2 on ischemia/reperfusion injury in
isolated rat hearts. Peptides. 26:501–507. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pfeil U, Aslam M, Paddenberg R, Quanz K,
Chang CL, Park JI, Gries B, Rafiq A, Faulhammer P, Goldenberg A, et
al: Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial
peptide that stabilizes pulmonary microvascular permeability. Am J
Physiol Lung Cell Mol Physiol. 297:L837–L845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu CL, Xie LX, Li M, Durairajan SS, Goto
S and Huang JD: Salvianolic acid B inhibits hydrogen
peroxide-induced endothelial cell apoptosis through regulating
PI3K/Akt signaling. PLoS One. 2:e13212007. View Article : Google Scholar : PubMed/NCBI
|
